Innovent Biologics Inc
HKEX:1801

Watchlist Manager
Innovent Biologics Inc Logo
Innovent Biologics Inc
HKEX:1801
Watchlist
Price: 34.9 HKD -0.85%
Market Cap: 57.2B HKD
Have any thoughts about
Innovent Biologics Inc?
Write Note

Intrinsic Value

The intrinsic value of one Innovent Biologics Inc stock under the Base Case scenario is 47.62 HKD. Compared to the current market price of 34.9 HKD, Innovent Biologics Inc is Undervalued by 27%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
47.62 HKD
Undervaluation 27%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Innovent Biologics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Innovent Biologics Inc
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Innovent Biologics Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Innovent Biologics Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

34.9 HKD
-0.85%
-0.85%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Innovent Biologics Inc
CN
Biotechnology
Market Cap
56.8B HKD
IPO
Oct 31, 2018
Employees
4 596
China
Market Cap
56.8B HKD
Industry
Biotechnology
IPO
Oct 31, 2018
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Innovent Biologics Inc

Provide an overview of the primary business activities
of Innovent Biologics Inc.

What unique competitive advantages
does Innovent Biologics Inc hold over its rivals?

What risks and challenges
does Innovent Biologics Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Innovent Biologics Inc.

Provide P/S
for Innovent Biologics Inc.

Provide P/E
for Innovent Biologics Inc.

Provide P/OCF
for Innovent Biologics Inc.

Provide P/FCFE
for Innovent Biologics Inc.

Provide P/B
for Innovent Biologics Inc.

Provide EV/S
for Innovent Biologics Inc.

Provide EV/GP
for Innovent Biologics Inc.

Provide EV/EBITDA
for Innovent Biologics Inc.

Provide EV/EBIT
for Innovent Biologics Inc.

Provide EV/OCF
for Innovent Biologics Inc.

Provide EV/FCFF
for Innovent Biologics Inc.

Provide EV/IC
for Innovent Biologics Inc.

Show me price targets
for Innovent Biologics Inc made by professional analysts.

What are the Revenue projections
for Innovent Biologics Inc?

How accurate were the past Revenue estimates
for Innovent Biologics Inc?

What are the Net Income projections
for Innovent Biologics Inc?

How accurate were the past Net Income estimates
for Innovent Biologics Inc?

What are the EPS projections
for Innovent Biologics Inc?

How accurate were the past EPS estimates
for Innovent Biologics Inc?

What are the EBIT projections
for Innovent Biologics Inc?

How accurate were the past EBIT estimates
for Innovent Biologics Inc?

Compare the revenue forecasts
for Innovent Biologics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Innovent Biologics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Innovent Biologics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Innovent Biologics Inc compared to its peers.

Compare the P/E ratios
of Innovent Biologics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Innovent Biologics Inc with its peers.

Analyze the financial leverage
of Innovent Biologics Inc compared to its main competitors.

Show all profitability ratios
for Innovent Biologics Inc.

Provide ROE
for Innovent Biologics Inc.

Provide ROA
for Innovent Biologics Inc.

Provide ROIC
for Innovent Biologics Inc.

Provide ROCE
for Innovent Biologics Inc.

Provide Gross Margin
for Innovent Biologics Inc.

Provide Operating Margin
for Innovent Biologics Inc.

Provide Net Margin
for Innovent Biologics Inc.

Provide FCF Margin
for Innovent Biologics Inc.

Show all solvency ratios
for Innovent Biologics Inc.

Provide D/E Ratio
for Innovent Biologics Inc.

Provide D/A Ratio
for Innovent Biologics Inc.

Provide Interest Coverage Ratio
for Innovent Biologics Inc.

Provide Altman Z-Score Ratio
for Innovent Biologics Inc.

Provide Quick Ratio
for Innovent Biologics Inc.

Provide Current Ratio
for Innovent Biologics Inc.

Provide Cash Ratio
for Innovent Biologics Inc.

What is the historical Revenue growth
over the last 5 years for Innovent Biologics Inc?

What is the historical Net Income growth
over the last 5 years for Innovent Biologics Inc?

What is the current Free Cash Flow
of Innovent Biologics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Innovent Biologics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Innovent Biologics Inc

Current Assets 11B
Cash & Short-Term Investments 15.9B
Receivables 1.4B
Other Current Assets -6.2B
Non-Current Assets 9.2B
Long-Term Investments 2.3B
PP&E 5.6B
Intangibles 987.4m
Other Non-Current Assets 363.2m
Current Liabilities 4.1B
Accounts Payable 220.6m
Accrued Liabilities 1.1B
Other Current Liabilities 2.8B
Non-Current Liabilities 3.7B
Long-Term Debt 2.3B
Other Non-Current Liabilities 1.4B
Efficiency

Earnings Waterfall
Innovent Biologics Inc

Revenue
7.5B CNY
Cost of Revenue
-1.3B CNY
Gross Profit
6.1B CNY
Operating Expenses
-7.2B CNY
Operating Income
-1.1B CNY
Other Expenses
-182.5m CNY
Net Income
-1.3B CNY

Free Cash Flow Analysis
Innovent Biologics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Innovent Biologics Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
ROIC is Increasing
Exceptional 1-Year Revenue Growth
32/100
Profitability
Score

Innovent Biologics Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Innovent Biologics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
61/100
Solvency
Score

Innovent Biologics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Innovent Biologics Inc

Wall Street analysts forecast Innovent Biologics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Innovent Biologics Inc is 57.84 HKD with a low forecast of 37.37 HKD and a high forecast of 71.19 HKD.

Lowest
Price Target
37.37 HKD
7% Upside
Average
Price Target
57.84 HKD
66% Upside
Highest
Price Target
71.19 HKD
104% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Innovent Biologics Inc?

Click here to dive deeper.

Dividends

Innovent Biologics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for Innovent Biologics Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one Innovent Biologics Inc stock?

The intrinsic value of one Innovent Biologics Inc stock under the Base Case scenario is 47.62 HKD.

Is Innovent Biologics Inc stock undervalued or overvalued?

Compared to the current market price of 34.9 HKD, Innovent Biologics Inc is Undervalued by 27%.

Back to Top